AI IN DRUG DISCOVERY USA Courtyard Boston Downtown, Boston

Artificial Intelligence (AI) is leading technological advancements in the pharmaceutical sector, poised to transform pre-clinical drug discovery by reducing costs by up to 40% and creating a market valued at up to $50 billion in the next decade. This transformative period is upon us, and the AI in Drug Discovery conference offers a unique opportunity to hear directly from experts and gain strategies to enhance your operations.

Scheduled for October 2024 in the United States, the AI in Drug Discovery Conference comes after a successful event in March 2024 in the UK. Since then, the industry has achieved a groundbreaking milestone: the first wholly AI-discovered and designed drug is now in Phase 2 clinical trials.

The conference is driven by the industry’s shift towards personalized therapies and novel drug candidates. Innovations in automation, in-silico modeling, and machine learning are increasing the efficiency of the drug discovery process, propelling growth in this expanding field and revolutionizing modern healthcare.